Study of Fluoxetine in Autism

Completed · Phase 3 · Has a placebo group

Conditions studied: Autistic Disorder

In brief

The purpose of this study is to assess the effect of fluoxetine orally dissolving tablets (ODT) on the repetitive behaviors core domain in children and adolescents with Autistic Disorder. The study will also investigate the effect of fluoxetine on the improvement of symptoms and the effects on daily living of the patient's family.

Key facts

Study ID
NCT00515320
Run by
Neuropharm
People needed
158
Starts
2007-08-01
Expected to finish
2009-01-01
Last updated by the study team
2012-04-27

Who can join

Age: 5 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.